Summary
Clinical Research Partners is enrolling adults for an influenza vaccine research study. Eligible participants include adults ages 12–64 with a high-risk medical condition or adults ages 65 and older. The study includes one dose of the study vaccine or a licensed influenza vaccine and a six-month commitment.
Age
12–64 years old with a high-risk medical condition OR 65 years and older